Smashed Peaches

Drug Research Studies

Havn Life Sciences Announces Listing Approval on the Frankfurt Stock Exchange – Yahoo Finance

HAVN)(FSE:5NP) (the "Company" or "Havn Life"), a biotechnology company focused on unlocking human potential using evidence-informed research, and developing standardized psychoactive compounds derived from plants and fungi, is pleased to announce that it has been accepted to list its common shares on the Frankfurt Stock Exchange (FSE) under the trading symbol (5NP). The Company’s shares are now cross-listed on the Canadian Securities Exchange (CSE) and the FSE.” data-reactid=”13″>VANCOUVER, BC / ACCESSWIRE / September 16, 2020 / Havn Life Sciences Inc. (CSE:HAVN)(FSE:5NP) (the “Company” or “Havn Life”), a biotechnology company focused on unlocking human potential using evidence-informed research, and developing standardized psychoactive compounds derived from plants and fungi, is pleased to announce that it has been accepted to list its common shares on the Frankfurt Stock Exchange (FSE) under the trading symbol (5NP). The Company’s shares are now cross-listed on the Canadian Securities Exchange (CSE) and the FSE.

“We have been exceptionally fortunate to have received investment inquiries internationally in such a small period of time,” says Tim Moore, Co-CEO of Havn Life. “Our team has been moving quickly to make Havn Life’s common shares available to European investors. The team will continue to work towards making our shares available to investors globally.”

havnlife.com and follow us on Facebook, Twitter and Instagram.” data-reactid=”22″>Havn Life Sciences is a biotechnology company on a mission to unlock human potential using evidence-informed research. The Company is focused on standardized, quality-controlled extraction of psychoactive compounds from plants and fungi, and the development of natural health care products from non-regulated compounds. Learn more at: havnlife.com and follow us on Facebook, Twitter and Instagram.

ir@havnlife.com 604 359 0060
Media: brittany@exvera.com 778 238 6096

https://www.accesswire.com/606271/Havn-Life-Sciences-Announces-Listing-Approval-on-the-Frankfurt-Stock-Exchange

” data-reactid=”28″>

View source version on accesswire.com:
https://www.accesswire.com/606271/Havn-Life-Sciences-Announces-Listing-Approval-on-the-Frankfurt-Stock-Exchange